Talking Points

Episode 105: POPULAR TAVI 04.11.2020 6:04 ↓

C. Michael Gibson and Jorn Brouwer discuss aspirin with or without clopidogrel after transcatheter aortic valve replacement.

Episode 104: EMPEROR Reduced 21.10.2020 16:43 ↓

C. Michael GIbson and Milton Packer Discuss empagliflozin in heart failure with reduced ejection fraction.

Episode 103: New ESC NSTEMI Guidelines 07.10.2020 9:42 ↓

C. Michael Gibson and Roxana Mehran discuss new ESC NSTEMI guidelines and more

Episode 102: Innovation in Mitral Valve Repair 02.09.2020 2:58 ↓

C. Michael Gibson and Steven Goldberg discuss REDUCE-FMR and sham-controlled trials in MV repair.

Episode 101: PARTNER 2A: 5-Year Outcomes 19.08.2020 2:54 ↓

C. Michael Gibson and Vinod Thourani discuss 5-year outcomes in this randomized trial of TAVR vs SAVR in intermediate-risk patients.

Episode 100: COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3 05.08.2020 5:22 ↓

Suzanne Baron and C. Michael Gibson discuss important new details from these two structural heart disease trials.

Episode 99: EVOLVE Short DAPT: 3-Month DAPT in Patients 22.07.2020 2:13 ↓

C. Michael Gibson and Ajay Kirtane review the results of this single-arm stent study.

Episode 98: #WomenAs1: The Battle for Gender Equality 15.07.2020 6:14 ↓

Roxana Mehran brings C. Michael Gibson up to speed on a campaign to promote talent in medicine by offering professional opportunities to female physicians.

Episode 97: TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin 02.07.2020 4:15 ↓

Usman Baber, who led this thrombogenicity substudy, walks C. Michael Gibson through the key findings.

Episode 96: IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCI 17.06.2020 5:09 ↓

C. Michael Gibson and Myeong-Ki Hong discuss 5-year outcomes in this randomized trial.

Episode 95: FORZA: Randomized Trial of Fractional Flow Reserve 20.05.2020 5:52 ↓

What are the respective values of FFR and OCT in guiding revascularization? C. Michael Gibson gets a primer from Francesco Burzotta.

Episode 94: Wearables - The Future Is Now 22.04.2020 6:04 ↓

C. Michael Gibson connects with Sameer Mehta and Francisco Fernandez to hear how new tech is poised to disrupt medical care.

Episode 93: Onyx ONE 17.04.2020 7:00 ↓

C. Michael Gibson learns about the Onyx ONE trial from Stephan Windecker.

Episode 92: TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin 01.04.2020 5:33 ↓

C. Michael Gibson reviews the randomized TWILIGHT trial results with Roxana Mehran.

Episode 91: Propensity Score-Matched Analysis 18.03.2020 4:12 ↓

Maurizio Taramasso walks C. Michael Gibson through randomized data focused on tricuspid valve disease.

Episode 90: MODEL U-SES: 3-Month DAPT in Patients at High Bleeding Risk 04.03.2020 3:37 ↓

C. Michael Gibson hears from Ken Kozuma about the single-arm MODEL U-SES study.

Episode 89: STS Registry: Mitral Valve Surgery Institutional Volume-Outcome Relationship in the US 24.02.2020 8:14 ↓

Vinay Badhwar discusses new data from the STS Registry addressing volume/outcome relationships for mitral valve surgery.

Episode 86: REMEDIAL III: Urine Flow Rate-Guided vs LVEDP-Guided Hydration 16.01.2020 4:15 ↓

C. Michael Gibsons sits down with Carlo Briguori to discuss the REMEDIAL III trial results.

Episode 85: REDUCE-FMR: Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation 07.01.2020 6:16 ↓

Samir Kapadia, Horst Sievert, and C. Michael Gibson discuss this randomized sham-controlled trial of the Carillon device.

Episode 84: A Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor in STEMI 18.12.2019 7:20 ↓

C. Michael Gibson and Dean Kereiakes discuss the first human use of RUC-4, designed for STEMI point-of-care treatment.

Episode 83: The Medically Ill Patients in AUGUSTUS 04.12.2019 3:07 ↓

C. Michael Gibson discusses the AUGUSTUS trial with Renato Lopes.

Episode 82: EXCEL: 5-Year Outcomes 20.11.2019 9:26 ↓

C. Michael Gibson speaks with Gregg Stone about EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease.

Episode 81: COAPT 3-Year Outcomes 06.11.2019 4:17 ↓

C. Michael Gibson speaks with Michael Mack about the COAPT Trial 3-year outcomes and results.

Episode 80: PARTNER 3 Low-Risk Computed Tomography Substudy 25.10.2019 5:47 ↓

C. Michael Gibson speaks with Raj Makkar about PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Episode 79: LEVANT: 5-Year Outcomes From Three Randomized Trials 16.10.2019 4:08 ↓

C. Michael Gibson speaks with Kenneth Ouriel about LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease